New Lynx FacTOR software-as-a-service solution is designed to minimize manual processes and accelerate release cycles in the ...

As the pharmaceutical industry heads into 2025 ... He leads initiatives to optimise asset management, operations, and maintenance, leveraging technologies like AI, IoT, and digital twins to ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...

NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it has promoted Warren Stone, ...

CERRITOS, Calif., March 24, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, ...

The following organizations have been chosen as Atlantic Canada’s Top Employers for 2025 (employee count refers to full-time ...

Home to seven of the world’s top 10 defence companies, some of the most hi-tech and innovative small and medium enterprises, ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

RAY pharmaceutical company from North India approached DSD consultants in Bombay (Mumbai) and requested them to identify a general manager for their Africa operations.

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years ...

Investing in TSX healthcare stocks such as Kneat.com can help Canadians generate outsized gains in 2025 and beyond.